BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 30535913)

  • 21. Horizontal DNA transfer from donor to host cells as an alternative mechanism of epithelial chimerism after allogeneic hematopoietic cell transplantation.
    Waterhouse M; Themeli M; Bertz H; Zoumbos N; Finke J; Spyridonidis A
    Biol Blood Marrow Transplant; 2011 Mar; 17(3):319-29. PubMed ID: 20837151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High frequency of donor chimerism after allogeneic transplantation of CD34+-selected peripheral blood cells.
    Briones J; Urbano-Ispizua A; Lawler M; Rozman C; Gardiner N; Marín P; Salgado C; Féliz P; McCann S; Montserrat E
    Exp Hematol; 1998 May; 26(5):415-20. PubMed ID: 9590658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative analysis of chimerism after allogeneic stem cell transplantation by real-time polymerase chain reaction with single nucleotide polymorphisms, standard tandem repeats, and Y-chromosome-specific sequences.
    Koldehoff M; Steckel NK; Hlinka M; Beelen DW; Elmaagacli AH
    Am J Hematol; 2006 Oct; 81(10):735-46. PubMed ID: 16838323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methyl-Guanine-Methyl-Transferase Transgenic Bone Marrow Transplantation Allows N,N-bis(2-chloroethyl)-Nitrosourea Driven Donor Mixed-Chimerism Without Graft-Versus-Host Disease, and With Donor-Specific Allograft Tolerance.
    Hu M; Kramer B; Zhang GY; Wang YM; Watson D; Howden B; McCowage G; Alexander IE; Gunning P; Alexander SI
    Transplantation; 2015 Dec; 99(12):2476-84. PubMed ID: 26177088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primer site polymorphisms: potential implications for bone marrow engraftment monitoring.
    Seywerd K; Allen RA; Dunn ST
    Genet Test Mol Biomarkers; 2009 Jun; 13(3):415-9. PubMed ID: 19405877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid single nucleotide polymorphism based method for hematopoietic chimerism analysis and monitoring using high-speed droplet allele-specific PCR and allele-specific quantitative PCR.
    Taira C; Matsuda K; Yamaguchi A; Uehara M; Sugano M; Okumura N; Honda T
    Clin Chim Acta; 2015 May; 445():101-6. PubMed ID: 25797898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of epithelial chimerism after bone marrow mesenchymal stromal cell infusion in intestinal transplant patients.
    Kilinc S; Gurkan UA; Guven S; Koyuncu G; Tan S; Karaca C; Ozdogan O; Dogan M; Tugmen C; Pala EE; Bayol U; Baran M; Kurtulmus Y; Pirim I; Kebapci E; Demirci U
    Transplant Proc; 2014; 46(6):2125-32. PubMed ID: 25131122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Developing an algorithm of informative markers for evaluation of chimerism after allogeneic bone marrow transplantation.
    Sellathamby S; Balasubramanian P; Sivalingam S; Shaji RV; Mathews V; George B; Viswabandya A; Srivastava A; Chandy M
    Bone Marrow Transplant; 2006 Apr; 37(8):751-5. PubMed ID: 16518431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
    Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
    J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell-free DNA characteristics and chimerism analysis in patients after allogeneic cell transplantation.
    Duque-Afonso J; Waterhouse M; Pfeifer D; Follo M; Duyster J; Bertz H; Finke J
    Clin Biochem; 2018 Feb; 52():137-141. PubMed ID: 29180242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early complete donor hematopoietic chimerism in peripheral blood indicates the risk of extensive graft-versus-host disease.
    Balon J; Hałaburda K; Bieniaszewska M; Reichert M; Bieniaszewski L; Piekarska A; Pawłowski R; Hellmann A
    Bone Marrow Transplant; 2005 Jun; 35(11):1083-8. PubMed ID: 15821766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor necrosis factor-alpha gene polymorphisms are associated with severity of acute graft-versus-host disease following matched unrelated donor bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium study.
    Goyal RK; Lin Y; Schultz KR; Ferrell RE; Kim Y; Fairfull L; Livote E; Yanik G; Atlas M
    Biol Blood Marrow Transplant; 2010 Jul; 16(7):927-936.e1. PubMed ID: 20100586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of chimerism and early engraftment after allogeneic peripheral blood stem cell or bone marrow transplantation by short tandem repeats.
    Frankel W; Chan A; Corringham RE; Shepherd S; Rearden A; Wang-Rodriguez J
    Am J Hematol; 1996 Aug; 52(4):281-7. PubMed ID: 8701946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical significance of dynamic monitoring of cell chimerism following allogeneic hematopoietic stem cell transplantation].
    Jiang Y; Wan LP; Wang C; Yan SK; Gao YR; Jiang JL; Yang J; Cai Y; Bai HT; Wei DL; Xie KC
    Zhonghua Xue Ye Xue Za Zhi; 2008 Oct; 29(10):667-71. PubMed ID: 19176059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of chimerism in epithelial cancers in transplanted patients.
    Leboeuf C; Ratajczak P; Vérine J; Elbouchtaoui M; Plassa F; Legrès L; Ferreira I; Sandid W; Varna M; Bousquet G; Verneuil L; Janin A
    Pathobiology; 2014; 81(3):114-22. PubMed ID: 24642582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A SYBR green-based real-time PCR method for detection of haemopoietic chimerism in allogeneic haemopoietic stem cell transplant recipients.
    Bai L; Deng YM; Dodds AJ; Milliken S; Moore J; Ma DD
    Eur J Haematol; 2006 Nov; 77(5):425-31. PubMed ID: 16899058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation.
    Pérez-Simón JA; Caballero D; Diez-Campelo M; Lopez-Pérez R; Mateos G; Cañizo C; Vazquez L; Vidriales B; Mateos MV; Gonzalez M; San Miguel JF
    Leukemia; 2002 Aug; 16(8):1423-31. PubMed ID: 12145680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Donor Chimerism of B Cells and Nature Killer Cells Provides Useful Information to Predict Hematologic Relapse following Allogeneic Hematopoietic Stem Cell Transplantation.
    Jiang Y; Wan L; Qin Y; Wang X; Yan S; Xie K; Wang C
    PLoS One; 2015; 10(7):e0133671. PubMed ID: 26226104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Addition of treosulfan to a nonmyeloablative conditioning regimen results in enhanced chimerism and immunologic tolerance in an experimental allogeneic bone marrow transplant model.
    Ploemacher RE; Johnson KW; Rombouts EJ; Etienne K; Westerhof GR; Baumgart J; White-Scharf ME; Down JD
    Biol Blood Marrow Transplant; 2004 Apr; 10(4):236-45. PubMed ID: 15077222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation between the kinetics of CD3+ chimerism and the incidence of graft-versus-host disease in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Rupa-Matysek J; Lewandowski K; Nowak W; Sawiński K; Gil L; Komarnicki M
    Transplant Proc; 2011 Jun; 43(5):1915-23. PubMed ID: 21693300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.